Huasheng Pharmaceutical

North China Pharmaceutical Huasheng (NCPC Huasheng) is a prominent subsidiary of the North China Pharmaceutical Group, specializing in the research, development, and large-scale manufacturing of anti-infective agents. The company is best known for its leadership in the production of glycopeptide antibiotics, specifically Norvancomycin Hydrochloride, which is used to treat severe infections caused by multi-drug resistant Gram-positive bacteria. Operating out of Shijiazhuang, China, NCPC Huasheng maintains high-standard GMP manufacturing facilities and supplies both active pharmaceutical ingredients (APIs) and finished dosage forms to domestic and international markets. Its business model integrates traditional pharmaceutical manufacturing with a focus on addressing unmet needs in the treatment of complex bacterial infections.